MAVA Members Paladin Capital Group and Vital Venture Capital participate in $10M funding of RubrYc Therapeutics

RubrYc Therapeutics, a San Ramon biotherapeutics discovery business, raised $10 million in funding. Third Point Ventures led the round and was joined by investors including Paladin Capital Group and Vital Venture Capital.

Click here to learn more.


2018-05-22T11:58:58+00:00May 22nd, 2018|